27 phenotypes from multigenic genotypes

Allelic Composition Genetic Background	Annotated Term	Reference
Asxl1tm1.1Iaai/Asxl1tm1.1Iaai Tet2tm1.1Iaai/Tet2tm1.1Iaai Tg(Mx1-cre)1Cgn/0 involves: 129S/SvEv * C57BL/6 * CBA	abnormal myelopoiesis	J:208092
	premature death	J:208092
Asxl1tm1.1Iaai/Asxl1tm1.1Iaai Tet2tm1.1Iaai/Tet2tm1.1Iaai Tg(VAV1-cre)1Graf/0 involves: 129S/SvEv * C57BL/6	normal hematopoietic system phenotype	J:208092
Tg(Vav1-Asxl1*Y588X)#Fcy/0 C57BL/6-Tg(Vav1-Asxl1*Y588X)#Fcy	abnormal definitive hematopoiesis	J:257690
	abnormal hematopoietic stem cell physiology	J:257690
	abnormal myeloid cell morphology	J:257690
	abnormal neutrophil morphology	J:257690
	abnormal spleen morphology	J:257690
	decreased body weight	J:257690
	decreased erythrocyte cell number	J:257690
	decreased hemoglobin content	J:257690
	decreased leukocyte cell number	J:257690
	decreased lymphocyte cell number	J:257690
	decreased megakaryocyte-erythroid progenitor cell number	J:257690
	enlarged spleen	J:257690
	hepatosplenomegaly	J:257690
	increased acute myeloid leukemia incidence	J:257690
	increased granulocyte monocyte progenitor cell number	J:257690
	increased hematopoietic stem cell number	J:257690
	increased leukocyte cell number	J:257690
	increased megakaryocyte cell number	J:257690
	increased monocyte cell number	J:257690
	increased myeloid cell number	J:257690
	increased myeloid sarcoma incidence	J:257690
	increased neutrophil cell number	J:257690
	increased number of Howell-Jolly bodies	J:257690
	premature death	J:257690
	thrombocytosis	J:257690